Literature DB >> 15173099

Reanalysis of cancer drugs: old drugs, new tricks.

George F Vande Woude1, Gary J Kelloff, Raymond W Ruddon, Han-Mo Koo, Caroline C Sigman, J Carl Barrett, Robert W Day, Adam P Dicker, Robert S Kerbel, David R Parkinson, William J Slichenmyer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15173099     DOI： 10.1158/1078-0432.CCR-03-0786

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  4 in total

Review 1.  Inorganic nanoparticles in cancer therapy.

Authors:  Sanjib Bhattacharyya; Rachel A Kudgus; Resham Bhattacharya; Priyabrata Mukherjee
Journal:  Pharm Res       Date:  2010-11-23       Impact factor: 4.200

Review 2.  Cancer biomarkers: selecting the right drug for the right patient.

Authors:  Gary J Kelloff; Caroline C Sigman
Journal:  Nat Rev Drug Discov       Date:  2012-02-10       Impact factor: 84.694

3.  Multiple circulating proangiogenic factors induced by sunitinib malate are tumor-independent and correlate with antitumor efficacy.

Authors:  John M L Ebos; Christina R Lee; James G Christensen; Anthony J Mutsaers; Robert S Kerbel
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-17       Impact factor: 11.205

4.  Cactus pear: a natural product in cancer chemoprevention.

Authors:  Da-ming Zou; Molly Brewer; Francisco Garcia; Jean M Feugang; Jian Wang; Roungyu Zang; Huaguang Liu; Changping Zou
Journal:  Nutr J       Date:  2005-09-08       Impact factor: 3.271
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.